135 related articles for article (PubMed ID: 8835109)
41. [Eradication of Helicobacter pylori in patients with recurrent abdominal pain using a triple drug treatment].
Ramírez Mayans J; Zamora Dávila E; Cervantes Bustamante R; Mata Rivera N; Oyervides García CI; Cuevas Schacht F; Sosa de Martínez MC
Rev Gastroenterol Mex; 1996; 61(4):310-3. PubMed ID: 9072781
[TBL] [Abstract][Full Text] [Related]
42. Antibacterial activity of teicoplanin against Clostridium difficile.
Wongwanich S; Kusum M; Phan-Urai R
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
[TBL] [Abstract][Full Text] [Related]
43. Combined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.
Vogt K; Rodloff AC; Hahn H
Infection; 1991; 19(3):138-9. PubMed ID: 1832417
[TBL] [Abstract][Full Text] [Related]
44. Differential effects of bismuth and salicylate salts on the antibiotic susceptibility of Pseudomonas aeruginosa.
Domenico P; O'Leary R; Cunha BA
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):170-5. PubMed ID: 1396732
[TBL] [Abstract][Full Text] [Related]
45. Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential.
Njume C; Jide AA; Ndip RN
Int J Mol Sci; 2011; 12(9):5652-65. PubMed ID: 22016616
[TBL] [Abstract][Full Text] [Related]
46. Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.
Coudron PE; Stratton CW
Antimicrob Agents Chemother; 1995 Dec; 39(12):2641-4. PubMed ID: 8592994
[TBL] [Abstract][Full Text] [Related]
47. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents.
McNulty CA; Dent J; Wise R
Antimicrob Agents Chemother; 1985 Dec; 28(6):837-8. PubMed ID: 2935076
[TBL] [Abstract][Full Text] [Related]
48. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
Vogt K; Warrelmann M; Hahn H
Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
[TBL] [Abstract][Full Text] [Related]
49. Amoxycillin tolerance in Helicobacter pylori.
Dore MP; Osato MS; Realdi G; Mura I; Graham DY; Sepulveda AR
J Antimicrob Chemother; 1999 Jan; 43(1):47-54. PubMed ID: 10381100
[TBL] [Abstract][Full Text] [Related]
50. In vitro activity of metronidazole against Helicobacter pylori as determined by agar dilution and agar diffusion.
Knapp CC; Ludwig MD; Washington JA
Antimicrob Agents Chemother; 1991 Jun; 35(6):1230-1. PubMed ID: 1929268
[TBL] [Abstract][Full Text] [Related]
51. Organobismuth compounds: activity against Helicobacter pylori.
Dahlgren A; Gløgård C; Gammelsaether M; Aasen AJ; Klaveness J; Berdal BP; Bergan T
Scand J Gastroenterol; 1999 Feb; 34(2):135-7. PubMed ID: 10192189
[TBL] [Abstract][Full Text] [Related]
52. Can Aminoglycosides Be Used as a New Treatment for
Lee KH; Park SY; Jeong SJ; Jung DH; Kim JH; Jeong SH; Kang IM; Song YG
Infect Chemother; 2019 Mar; 51(1):10-20. PubMed ID: 30941933
[TBL] [Abstract][Full Text] [Related]
53. Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole.
Larsen T
Oral Microbiol Immunol; 2002 Oct; 17(5):267-71. PubMed ID: 12354206
[TBL] [Abstract][Full Text] [Related]
54. Reduction of capsular polysaccharide and potentiation of aminoglycoside inhibition in gram-negative bacteria by bismuth subsalicylate.
Domenico P; Landolphi DR; Cunha BA
J Antimicrob Chemother; 1991 Dec; 28(6):801-10. PubMed ID: 1816178
[TBL] [Abstract][Full Text] [Related]
55. Metronidazole susceptibility testing of Helicobacter pylori with the PDM epsilometer test (E test).
von Recklinghausen G; Ansorg R
Zentralbl Bakteriol; 1995 Jan; 282(1):83-5. PubMed ID: 7734833
[TBL] [Abstract][Full Text] [Related]
56. Proposed mechanism for metronidazole resistance in Helicobacter pylori.
Cederbrant G; Kahlmeter G; Ljungh A
J Antimicrob Chemother; 1992 Feb; 29(2):115-20. PubMed ID: 1506325
[TBL] [Abstract][Full Text] [Related]
57. In vitro susceptibility of Helicobacter pylori to trospectomycin, pirlimycin (U-57930E), mirincamycin (U-24729A) and N-demethyl clindamycin (U-26767A).
Westblom TU; Midkiff BR; Czinn SJ
Eur J Clin Microbiol Infect Dis; 1993 Jul; 12(7):560-2. PubMed ID: 8404921
[TBL] [Abstract][Full Text] [Related]
58. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics.
Andreasen JJ; Andersen LP
Acta Pathol Microbiol Immunol Scand B; 1987 Apr; 95(2):147-9. PubMed ID: 3591312
[TBL] [Abstract][Full Text] [Related]
59. [Antibacterial activity of 16 antibiotics against Helicobacter pylori].
Hosaka Y; Irinoda K; Nakano R; Kitasato H; Okamoto R; Saigenji K; Inoue M
Jpn J Antibiot; 2000 Oct; 53(10):623-30. PubMed ID: 11190047
[TBL] [Abstract][Full Text] [Related]
60. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate.
Chen R; So MH; Yang J; Deng F; Che CM; Sun H
Chem Commun (Camb); 2006 Jun; (21):2265-7. PubMed ID: 16718324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
